Categories
Avenues Becoming Your Own Advocate

Your Mind & Cancer Treatment: The Latest Research on Chemotherapy-related Cognitive Decline

INTRODUCTION
In the Winter 2005 issue of Avenues, we discussed the important issue of how the mind can be negatively impacted by various conventional cancer treatments. Commonly referred to as “chemo brain” or “chemo fog,” patients often experience adverse effects in cognitive function. The original article, which provides general information on this topic, is available by clicking here.

Categories
Avenues Becoming Your Own Advocate

Your Mind and Cancer Treatment: Understanding and Addressing Cognitive Decline

Commonly referred to as “chemo brain” or “chemo fog,” adverse effects in cognitive function are often experienced by patients going through various cancer treatments. This issue is frequently a topic in cancer support group meetings1 and has been investigated in clinical studies where it is variously referred to as “chemotherapy-related cognitive dysfunction,” “cognitive deficit,” or “cognitive decline.”2 Changes in cognitive ability because of chemotherapy treatment may be a type of autoimmune response or the result of chemical toxicity, oxidative damage, or inflammation in neurons.3